Laurel Wealth Advisors (North Carolina)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-29
Closed -$2.77K – 259
2025
Q4
$2.77K Buy
+29
New +$2.84K ﹤0.01% 591
2025
Q2
– Sell
-12
Closed -$1.21K – 259
2025
Q1
$1.21K Buy
+12
New +$1.21K ﹤0.01% 621

Other funds holding BSX

Laurel Wealth Advisors (North Carolina)'s BSX Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 29 shares — an estimated $2.77K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in BSX in Q1 2025 and held it in 2 quarters. The position peaked at $2.77K in Q4 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 29 Boston Scientific shares in Q1 2026, an estimated $2.77K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Boston Scientific in Q1 2025 and held it in 2 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Boston Scientific position peaked at $2.77K in Q4 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.